Preclinical News and Research

RSS
Sangart commences MP4OX Phase 2b study in acute traumatic injury

Sangart commences MP4OX Phase 2b study in acute traumatic injury

Bayer's submission of IND for BAY 94-9343 triggers $2M milestone payment to ImmunoGen

Bayer's submission of IND for BAY 94-9343 triggers $2M milestone payment to ImmunoGen

Milestone completes $13 million round of equity financing

Milestone completes $13 million round of equity financing

UC Davis, Jackson Laboratory and NCI partner for human clinical trials on cancer

UC Davis, Jackson Laboratory and NCI partner for human clinical trials on cancer

Quintiles, Kareus partner to advance KU-046 diabetes drug candidate into clinical trials

Quintiles, Kareus partner to advance KU-046 diabetes drug candidate into clinical trials

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

FDA accepts ZIOPHARM's IND for ZIN ATI-001 to treat melanoma

FDA accepts ZIOPHARM's IND for ZIN ATI-001 to treat melanoma

Scripps Research receives $2.2M NIH grant to develop novel therapeutics for substance abuse

Scripps Research receives $2.2M NIH grant to develop novel therapeutics for substance abuse

Eli Lilly, Synthes collaborate to develop osteoinductive products

Eli Lilly, Synthes collaborate to develop osteoinductive products

Metabolomics analysis shows 3IS as early predictive, sensitive biomarker of acute kidney injury

Metabolomics analysis shows 3IS as early predictive, sensitive biomarker of acute kidney injury

Clovis, Avila select CO-1686 drug candidate for EGFR Mutant-Selective Inhibitor program

Clovis, Avila select CO-1686 drug candidate for EGFR Mutant-Selective Inhibitor program

Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Rockefeller, Scripps Research develop first genetically humanized mouse model for hepatitis C

Rockefeller, Scripps Research develop first genetically humanized mouse model for hepatitis C

FDA accepts Adamis IND for APC-100 to treat prostate cancer

FDA accepts Adamis IND for APC-100 to treat prostate cancer

Rosa, Profil Institute partner to offer simulation technology for diabetes and obesity clinical trials

Rosa, Profil Institute partner to offer simulation technology for diabetes and obesity clinical trials

NYU Cancer Institute scientists present new research findings at ASCO 2011

NYU Cancer Institute scientists present new research findings at ASCO 2011

Patient enrollment complete in BioMimetic's Augment Rotator Cuff pilot trial

Patient enrollment complete in BioMimetic's Augment Rotator Cuff pilot trial

FDA grants orphan drug designation for Edison's EPI-743 to treat inherited mitochondrial diseases

FDA grants orphan drug designation for Edison's EPI-743 to treat inherited mitochondrial diseases

Promising results from KAI-4169 program for CKD-MBD presented at ENDO 2011

Promising results from KAI-4169 program for CKD-MBD presented at ENDO 2011

LLS announces four new Academic Concierge partnerships for cancer drug development

LLS announces four new Academic Concierge partnerships for cancer drug development

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.